499 assets in Hepatocellular Carcinoma

Therapeutic assets addressing Hepatocellular Carcinoma, rated under Floatz methodology v0.2 and sorted by current rating.

Asset	Sponsor	Phase	Rating
Huaier Granule Hepatocellular Carcinoma	Tongji Hospital	P4	BBB (75)
Fluorouracilum Hepatocellular Carcinoma	Li Qiang	P4	BBB (72)
Oxaliplatin Hepatocellular Carcinoma	Li Qiang	P4	BBB (72)
Theprubicin Hepatocellular Carcinoma	RWTH Aachen University	P4	BB (71)
Adriamycin Hepatocellular Carcinoma	VA Office of Research and Development	P4	BB (70)
Epirubicin Hepatocellular Carcinoma	Fudan University	P4	BB (70)
Iodized Ethyl Esters Of Poppyseed Fatty Acids Hepatocellular Carcinoma	RWTH Aachen University	P4	BB (70)
nrt6003 Hepatocellular Carcinoma	Second Affiliated Hospital of Guangzhou Medical University	P3	BB (70)
Penpulimab Hepatocellular Carcinoma	West China Hospital	P3	BB (70)
Cyclophosphamide Hepatocellular Carcinoma	Roswell Park Cancer Institute	P3	BB (69)
Donafenib Hepatocellular Carcinoma	Haibo Shao	P4	BB (69)
L-Cysteinamide, D-Phenylalanyl-L-Cysteinyl-L-Phenylalanyl-D-Tryptophyl-L-Lysyl-L-Threonyl-N-(2-Hydroxy-1-(Hydroxymethyl)Propyl)-, Cyclic (2->7)-Disulfide, (R-(R,R))- Hepatocellular Carcinoma	Clinica Universidad de Navarra, Universidad de Navarra	P3	BB (69)
Lenvatinib Hepatocellular Carcinoma	Zhejiang Haichang Biotech Co., Ltd.	P4	BB (69)
Sorafenib Hepatocellular Carcinoma	Shunda Du	P4	BB (69)
Pembrolizumab Hepatocellular Carcinoma	Fudan University	P3	BB (68)
Tenofovir Alafenamide Hepatocellular Carcinoma	Taipei Veterans General Hospital, Taiwan	P4	BB (68)
Atezolizumab Hepatocellular Carcinoma	Icahn School of Medicine at Mount Sinai	P4	BB (67)
AK105 Hepatocellular Carcinoma	Chia Tai Tianqing Pharmaceutical Group Co., Ltd.	P3	BB (66)
Apixaban Hepatocellular Carcinoma	Mansoura University	P4	BB (66)
Cabozantinib Hepatocellular Carcinoma	Exelixis	P4	BB (66)
Carboplatin Hepatocellular Carcinoma	University of Texas Southwestern Medical Center	P4	BB (66)
Ivonescimab Hepatocellular Carcinoma	Akeso	P4	BB (66)
Rivoceranib Hepatocellular Carcinoma	Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University	P3	BB (66)
Albumin Aggregated Hepatocellular Carcinoma	Sirtex Medical	P4	BB (65)
Carvedilol Hepatocellular Carcinoma	Tongji Hospital	P4	BB (65)
Crizotinib Hepatocellular Carcinoma	Ariad Pharmaceuticals	P3	BB (65)
Eob-Dtpa Hepatocellular Carcinoma	Charite University, Berlin, Germany	P4	BB (65)
Immunoglobulin G1, Anti-(Human Vascular Endothelial Growth Factor Receptor Type Vegfr-2 Extracellular Domain) (Human Monoclonal Imc-1121B .Gamma.-Chain), Disulphide With Human Monoclonal Imc-1121B .Kappa.-Chain, Dimer Hepatocellular Carcinoma	Fudan University	P3	BB (65)
Irinotecan Hepatocellular Carcinoma	University of Florida	P3	BB (65)
Nad(Sup +) Hepatocellular Carcinoma	Anhui Provincial Hospital	P4	BB (65)
Nivolumab Hepatocellular Carcinoma	Zhejiang Haichang Biotech Co., Ltd.	P3	BB (65)
Osimertinib Hepatocellular Carcinoma	AstraZeneca	P3	BB (65)
Tislelizumab Hepatocellular Carcinoma	Haibo Shao	P4	BB (65)
Zanzalintinib Hepatocellular Carcinoma	Exelixis	P3	BB (65)
Celecoxib Hepatocellular Carcinoma	Emory University	P4	BB (64)
Cis-Diamminedichloroplatinum Ii Hepatocellular Carcinoma	Shandong Cancer Hospital and Institute	P3	BB (64)
Everolimus Hepatocellular Carcinoma	Captor Therapeutics S.A.	P4	BB (64)
Recombinant Human Adenovirus Type 5 Hepatocellular Carcinoma	Henan Cancer Hospital	P4	BB (64)
Tacrolimus Hepatocellular Carcinoma	Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins	P4	BB (64)
Tirapazamine Hepatocellular Carcinoma	Zhejiang Raygene Pharmaceuticals Co., Ltd	P2/3	BB (64)
Catequentinib Hepatocellular Carcinoma	Nanfang Hospital, Southern Medical University	P3	B (63)
Enzalutamide Hepatocellular Carcinoma	Exelixis	P3	B (63)
Icaritin Hepatocellular Carcinoma	Northern Jiangsu People's Hospital	P3	B (63)
Immunoglobulin G2, Anti-(Human Ctla-4 (Antigen)) (Human Monoclonal Cp-675206 Clone 11.2.1 Heavy Chain) Disulphide With Human Monoclonal Cp-675206 Clone 11.2.1 Light Chain, Dimer Hepatocellular Carcinoma	Riboscience, LLC.	P4	B (63)
Ipilimumab Hepatocellular Carcinoma	University of Hawaii	P3	B (63)
Toripalimab Hepatocellular Carcinoma	Sun Yat-sen University	P3	B (63)
Azathioprine Hepatocellular Carcinoma	Baylor Research Institute	P4	B (62)
Dexasone Hepatocellular Carcinoma	Shunda Du	P3	B (62)
Huachansu Hepatocellular Carcinoma	Beijing Shenogen Biomedical Co., Ltd	P3	B (62)
ibi310 Hepatocellular Carcinoma	Innovent Biopharmaceutical Technology (Hangzhou) Co., LTD.	P3	B (62)

Showing 1 to 50 of 499 assets

PreviousPage 1 of 10Next